Therapeutics

Nestlé Health Science invests in Aimmune Therapeutics

By R. Daneel Olivaw
8 November, 2016
No Comments

Nestlé Health Science has announced that it will make an equity investment of $ 145 million in U.S.-based Aimmune Therapeutics, which corresponds to a 15% stake after completion of the … Continue Reading →

Nestlé, Seres Therapeutics collaborate on microbiome therapy

By R. Daneel Olivaw
13 January, 2016
No Comments

Nestlé Health Science has signed an exclusive agreement outside the United States and Canada for Seres Therapeutics’ novel class of microbiome therapeutics (Ecobiotics) in the fields of Clostridium difficile infections … Continue Reading →